Brandon D'Arcy

Brandon D'Arcy has a comprehensive work experience in the field of scientific research and structural biology. Brandon currently holds the position of Principal Scientist in Structural Biology at Kimia Therapeutics since June 2023. Prior to this, they worked as a Senior Scientist at Loxo Oncology at Lilly from October 2021 to June 2023. Earlier in their career, they served as a Postdoctoral Researcher at the University of South Alabama Mitchell Cancer Institute from December 2016 to September 2021.

Brandon D'Arcy completed their education from 2012 to 2016 at the University of South Alabama, where they obtained a Doctor of Philosophy (PhD) degree in the Department of Biochemistry and Molecular Biology.